Shrinath Superspeciality Healthcentre Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 02-01-2025
- Paid Up Capital ₹ 2.50 M
as on 02-01-2025
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.10 M
as on 02-01-2025
- Revenue -2.12%
(FY 2017)
- Profit 137.47%
(FY 2017)
- Ebitda 159.46%
(FY 2017)
- Net Worth 9.41%
(FY 2017)
- Total Assets 32.91%
(FY 2017)
About Shrinath Superspeciality Healthcentre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹4.10 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Deepali Marwaha and Arti Bhatia serve as directors at the Company.
- CIN/LLPIN
U85100PB2013PTC037260
- Company No.
037260
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Mar 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Jalandhar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shrinath Superspeciality Healthcentre?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepali Marwaha  | Director | 22-Mar-2013 | Current |
| Arti Bhatia | Director | 22-Mar-2013 | Current |
Financial Performance of Shrinath Superspeciality Healthcentre.
Shrinath Superspeciality Healthcentre Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 2.12% decrease. The company also saw a substantial improvement in profitability, with a 137.47% increase in profit. The company's net worth moved up by a moderate rise of 9.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shrinath Superspeciality Healthcentre?
In 2017, Shrinath Superspeciality Healthcentre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Jul 2017 | ₹2.10 M | Satisfied |
State Bank Of India Creation Date: 14 Jan 2014 | ₹2.00 M | Satisfied |
How Many Employees Work at Shrinath Superspeciality Healthcentre?
Shrinath Superspeciality Healthcentre has a workforce of 26 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shrinath Superspeciality Healthcentre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shrinath Superspeciality Healthcentre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.